Takayoshi Suga 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（16 件）

• [2026] Safety and Efficacy of Stereotactic Body Radiation Therapy in Very Elderly Patients (≥80 Years) with Solitary Hepatocellular Carcinoma
  DOI: https://doi.org/10.3390/cancers18111809
• [2026] THU-188 Age-related clinical features of metabolic dysfunction associated steatotic liver disease in a real-world cohort
  DOI: https://doi.org/10.1016/s0168-8278(26)01577-1
• [2026] Long‐Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus‐Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort Study
  DOI: https://doi.org/10.1111/hepr.70172
• [2026] Efficacy of Lenvatinib as Second-Line Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
  DOI: https://doi.org/10.3390/curroncol33030159
• [2026] Sodium-glucose cotransporter-specific substrate αMG stimulates endogenous glucagon secretion and ameliorates obesity-associated metabolic disorders in mice
  DOI: https://doi.org/10.1016/j.molmet.2026.102324
• [2025] Current Status and Issues of Hepatitis B Reactivation in Gunma Prefecture
  DOI: https://doi.org/10.2957/kanzo.66.447
• [2025] Association Between Liver Injury and Pneumonia in Patients Hospitalized with COVID-19, -With a Focus on Pregnant Women
  DOI: https://doi.org/10.2957/kanzo.66.71
• [2024] Evaluation of the Efficacy of Lusutrombopag for Chronic Liver Disease Based on Pre‐Treatment Platelet Counts: A Retrospective Multicenter Study
  DOI: https://doi.org/10.1002/jgh3.70081
• [2023] Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab
  DOI: https://doi.org/10.1002/ccr3.7875
• [2022] P16-2 A retrospective analysis of pembrolizumab in patients with high microsatellite instability cholangiocarcinoma
  DOI: https://doi.org/10.1016/j.annonc.2022.05.252

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。